NewLink Genetics is a venture capital fund based in Ames, Iowa, United States, founded in 1999 The firm specializes in investing in innovative biotechnology companies that focus on developing novel therapies With an investment scale of approximately $43,400,000, NewLink Genetics aims to support early-stage companies with promising technologies The fund is committed to advancing healthcare solution...